Carbylan Therapeutics, Inc. 4
4 · Carbylan Therapeutics, Inc. · Filed Jan 5, 2016
Insider Transaction Report
Form 4
Renzi David
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-01-04+283,000→ 283,000 totalExercise: $3.33Exp: 2026-01-04→ Common Stock (283,000 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to 1/48 of the underlying shares upon each monthly anniversary of the vesting commencement date of January 1, 2016.